Browsing Tag
diabetes care
11 posts
What’s next after Zepbound? Inside Eli Lilly and Company’s pipeline beyond GLP-1
Discover which drugs Eli Lilly and Company is betting on after Zepbound, including oral GLP-1 pills and next-generation incretins that could redefine the global obesity treatment market.
December 8, 2025
Sandstone’s Easydrip Plus debuts in Uzbekistan: Can mid-tier pen needles raise diabetes care standards?
Sandstone's Easydrip Plus pen needles launch in Uzbekistan, bridging the gap in diabetes care between premium brands and low-end options. Read more now.
September 2, 2025
Can Trividia’s low-cost insulin pen needles improve diabetes care across the NHS?
Trividia Health UK launches TRUEplus 5-Bevel Pen Needles in the UK, aiming to improve diabetes injection comfort at a lower cost. Find out what this means.
August 1, 2025
Tandem Diabetes Care expands insulin pump integration with Abbott’s FreeStyle Libre 3 Plus sensor for U.S. diabetes patients
Tandem Diabetes Care integrates t:slim X2 insulin pump with Abbott’s FreeStyle Libre 3 Plus in the U.S., advancing automated insulin delivery personalization.
June 24, 2025
Abbott’s Healthy Food Rx program shows clinical benefits for diabetes patients in low-income settings
Abbott’s Healthy Food Rx clinical trial improves diet, A1C levels, and health in underserved diabetes patients, advancing the food-is-medicine model in the U.S.
June 22, 2025
How are AI models and new clinical treatments reshaping diabetes care after the 2025 ADA conference?
ADA 2025 highlights AI diagnostics and breakthrough injectables in diabetes care, signaling early detection and superior glycemic control in clinical trials.
June 21, 2025
FDA approves first generic liraglutide injection for Type 2 diabetes treatment
In a significant milestone for diabetes care, the U.S. Food and Drug Administration (FDA) has approved the first…
December 24, 2024
Cardinal Health takes $3.9bn leap into specialty healthcare with two key acquisitions
In a bold move to expand its reach in specialty healthcare, Cardinal Health has announced it will acquire…
November 13, 2024
MTD Group enhances global reach with acquisition of Ypsomed’s pen needles and blood glucose monitoring systems
Medical Technology and Devices (MTD) has announced the successful completion of its acquisition of Ypsomed’s Pen Needles and…
August 2, 2024
Roche bags CE Mark for Accu-Chek SmartGuide CGM solution
Roche has announced a significant advancement in diabetes management with the CE Mark approval of its Accu-Chek SmartGuide…
July 9, 2024